What health risks are associated with low HDL cholesterol?

Low HDL cholesterol increases cardiovascular disease risk, inflammation, and metabolic dysfunction. Optimal HDL levels above 60 mg/dL protect heart health and reduce chronic disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

High-density lipoprotein (HDL) cholesterol is often called "good cholesterol" for good reason. Unlike its counterpart LDL cholesterol, which can contribute to arterial plaque buildup, HDL cholesterol acts as your cardiovascular system's cleanup crew, transporting cholesterol away from your arteries and back to your liver for disposal. When HDL levels drop too low, this protective mechanism becomes compromised, opening the door to a cascade of serious health risks that extend far beyond your heart.

Understanding the health implications of low HDL cholesterol is crucial for anyone looking to optimize their long-term wellness. While much attention is given to lowering LDL cholesterol, maintaining adequate HDL levels is equally important for cardiovascular protection and overall metabolic health.

Understanding HDL Cholesterol and Optimal Levels

HDL cholesterol is a lipoprotein that carries cholesterol from peripheral tissues back to the liver through a process called reverse cholesterol transport. This mechanism helps prevent cholesterol accumulation in arterial walls, reducing the risk of atherosclerosis and cardiovascular disease.

HDL Cholesterol Level Categories and Health Implications

HDL Level (mg/dL)CategoryCardiovascular RiskRecommended Action
Men: <40, Women: <50Men: <40, Women: <50LowHigh RiskImmediate lifestyle intervention
Men: 40-49, Women: 50-59Men: 40-49, Women: 50-59Borderline LowModerate RiskLifestyle modifications recommended
≥60≥60OptimalProtectiveMaintain current lifestyle

HDL cholesterol targets vary by sex due to hormonal differences affecting lipid metabolism.

According to the American Heart Association and National Cholesterol Education Program, HDL cholesterol levels are categorized as follows: low (less than 40 mg/dL for men and less than 50 mg/dL for women), borderline low (40-49 mg/dL for men and 50-59 mg/dL for women), and optimal (60 mg/dL or higher for both sexes). However, research suggests that higher HDL levels within the optimal range provide even greater cardiovascular protection.

The Protective Role of HDL

Beyond cholesterol transport, HDL particles possess anti-inflammatory, antioxidant, and anti-thrombotic properties. They help maintain endothelial function, the health of blood vessel walls, and support the body's natural defense mechanisms against cardiovascular disease. When HDL levels are low, these protective functions are diminished, leaving the cardiovascular system more vulnerable to damage.

Cardiovascular Disease Risks

The most well-established risk associated with low HDL cholesterol is cardiovascular disease. Multiple large-scale studies have consistently shown an inverse relationship between HDL levels and heart disease risk, meaning that as HDL levels decrease, cardiovascular risk increases significantly.

Heart Attack and Coronary Artery Disease

Low HDL cholesterol is an independent risk factor for coronary artery disease and myocardial infarction (heart attack). The Framingham Heart Study, one of the longest-running cardiovascular research projects, found that for every 1 mg/dL increase in HDL cholesterol, there was a 2-3% decrease in coronary heart disease risk. Conversely, individuals with HDL levels below 40 mg/dL have a significantly higher risk of developing coronary artery disease, even when other cholesterol markers appear normal.

The mechanism behind this increased risk involves the reduced capacity for reverse cholesterol transport when HDL levels are low. Without adequate HDL to remove cholesterol from arterial walls, atherosclerotic plaques can form more readily, narrowing coronary arteries and potentially leading to heart attacks.

Stroke Risk

Low HDL cholesterol also increases the risk of ischemic stroke, the most common type of stroke caused by blocked blood flow to the brain. Research published in the journal Stroke found that individuals with HDL levels below 35 mg/dL had a 53% higher risk of ischemic stroke compared to those with levels above 45 mg/dL. This increased risk persists even after adjusting for other cardiovascular risk factors like blood pressure and diabetes.

Metabolic and Inflammatory Consequences

Low HDL cholesterol often occurs as part of a broader pattern of metabolic dysfunction, contributing to and exacerbating various health conditions beyond cardiovascular disease.

Metabolic Syndrome

Low HDL cholesterol is one of the five criteria used to diagnose metabolic syndrome, a cluster of conditions that significantly increase the risk of heart disease, stroke, and type 2 diabetes. The other components include elevated waist circumference, high triglycerides, elevated blood pressure, and elevated fasting glucose. When HDL cholesterol falls below 40 mg/dL in men or 50 mg/dL in women, it contributes to this dangerous metabolic profile.

Individuals with metabolic syndrome have a five-fold increased risk of developing type 2 diabetes and a two-fold increased risk of cardiovascular disease over the next 5-10 years. Regular monitoring of HDL cholesterol alongside other metabolic markers is essential for early detection and intervention.

Chronic Inflammation

HDL particles have potent anti-inflammatory properties, helping to reduce systemic inflammation throughout the body. When HDL levels are low, this anti-inflammatory protection is diminished, potentially leading to increased levels of inflammatory markers like C-reactive protein (CRP) and interleukin-6.

Chronic inflammation is now recognized as a key driver of numerous health conditions, including cardiovascular disease, diabetes, certain cancers, and neurodegenerative diseases. The loss of HDL's anti-inflammatory effects when levels are low may contribute to the development and progression of these conditions.

Additional Health Risks and Complications

Type 2 Diabetes Risk

Low HDL cholesterol is strongly associated with insulin resistance and an increased risk of developing type 2 diabetes. The relationship is bidirectional: low HDL can contribute to insulin resistance, while insulin resistance can further lower HDL levels, creating a vicious cycle of metabolic dysfunction.

Studies have shown that individuals with HDL levels below 35 mg/dL have a 40% higher risk of developing type 2 diabetes compared to those with levels above 45 mg/dL. This risk persists even after accounting for other diabetes risk factors like obesity and family history.

Cognitive Function and Dementia

Emerging research suggests that low HDL cholesterol may also impact brain health and cognitive function. HDL particles can cross the blood-brain barrier and may play a role in protecting against neuroinflammation and oxidative stress in the brain.

Some studies have found associations between low HDL levels and increased risk of cognitive decline and dementia, though more research is needed to establish definitive causal relationships. The potential mechanisms include reduced antioxidant protection in the brain and impaired clearance of amyloid plaques associated with Alzheimer's disease.

Causes and Risk Factors for Low HDL

Understanding what causes low HDL cholesterol can help identify individuals at risk and guide targeted interventions. Several factors can contribute to decreased HDL levels, ranging from genetic predisposition to lifestyle choices.

Genetic factors play a significant role, with certain genetic variants affecting HDL production and metabolism. However, lifestyle factors often have an even greater impact on HDL levels and can be modified through targeted interventions.

  • Sedentary lifestyle and lack of regular physical activity
  • Obesity, particularly abdominal obesity
  • Smoking and tobacco use
  • High carbohydrate, low-fat diets
  • Insulin resistance and type 2 diabetes
  • Certain medications, including beta-blockers and anabolic steroids
  • Chronic kidney disease
  • Inflammatory conditions like rheumatoid arthritis

Testing and Monitoring HDL Cholesterol

Regular testing of HDL cholesterol is essential for assessing cardiovascular risk and monitoring the effectiveness of interventions. HDL cholesterol is typically measured as part of a comprehensive lipid panel, which also includes total cholesterol, LDL cholesterol, and triglycerides.

The standard recommendation is to test lipid levels every 4-6 years for adults over 20, but individuals with risk factors for cardiovascular disease may need more frequent monitoring. This includes people with diabetes, high blood pressure, family history of heart disease, or those taking medications that affect cholesterol levels.

Advanced lipid testing may also include measurements of HDL particle number and size, as well as apolipoprotein A1 (ApoA1), the main protein component of HDL particles. These additional markers can provide more detailed insights into HDL function and cardiovascular risk.

Strategies for Improving HDL Cholesterol

The good news is that HDL cholesterol levels can often be improved through lifestyle modifications and, when necessary, medical interventions. Unlike LDL cholesterol, which responds well to dietary changes and medications, HDL cholesterol is more responsive to lifestyle factors, particularly physical activity.

Exercise and Physical Activity

Regular aerobic exercise is one of the most effective ways to raise HDL cholesterol levels. Studies show that consistent aerobic activity can increase HDL levels by 5-15%, with greater improvements seen in individuals who were previously sedentary. The American Heart Association recommends at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity activity per week.

Resistance training also contributes to HDL improvement, particularly when combined with aerobic exercise. High-intensity interval training (HIIT) has shown particular promise for improving HDL levels and overall cardiovascular fitness.

Dietary Modifications

While diet has a more modest effect on HDL compared to exercise, certain dietary patterns can support healthy HDL levels. The Mediterranean diet, rich in olive oil, nuts, fish, and vegetables, has been associated with higher HDL levels and improved cardiovascular outcomes.

  • Include healthy fats from sources like olive oil, avocados, and nuts
  • Consume fatty fish rich in omega-3 fatty acids twice per week
  • Limit refined carbohydrates and added sugars
  • Moderate alcohol consumption (if appropriate) may modestly increase HDL
  • Maintain a healthy weight through portion control and balanced nutrition

Taking Control of Your HDL Cholesterol

Low HDL cholesterol represents a significant but often overlooked risk factor for cardiovascular disease and other serious health conditions. The protective effects of adequate HDL levels extend beyond cholesterol transport to include anti-inflammatory, antioxidant, and metabolic benefits that support overall health and longevity.

The key to managing HDL cholesterol lies in understanding your current levels through regular testing and implementing evidence-based lifestyle strategies to optimize them. While genetic factors influence baseline HDL levels, lifestyle modifications can make a meaningful difference in both HDL cholesterol and overall cardiovascular risk.

By prioritizing regular physical activity, maintaining a healthy weight, following a heart-healthy diet, and avoiding smoking, you can take proactive steps to raise your HDL cholesterol and reduce your risk of cardiovascular disease. Regular monitoring through comprehensive lipid testing allows you to track your progress and adjust your approach as needed, ensuring that your HDL cholesterol remains in the optimal range for long-term health protection.

References

  1. Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977). High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. The American Journal of Medicine, 62(5), 707-714.[DOI]
  2. Emerging Risk Factors Collaboration. (2009). Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 302(18), 1993-2000.[PubMed][DOI]
  3. Barter, P., Gotto, A. M., LaRosa, J. C., et al. (2007). HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. New England Journal of Medicine, 357(13), 1301-1310.[PubMed][DOI]
  4. Kodama, S., Tanaka, S., Saito, K., et al. (2007). Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Archives of Internal Medicine, 167(10), 999-1008.[PubMed][DOI]
  5. Rosenson, R. S., Brewer Jr, H. B., Davidson, W. S., et al. (2012). Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation, 125(15), 1905-1919.[PubMed][DOI]
  6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106(25), 3143-3421.[PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my HDL cholesterol at home?

You can test your HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes HDL cholesterol testing along with other crucial cardiovascular markers, providing lab-quality results from the comfort of your home.

What is considered a dangerously low HDL cholesterol level?

HDL cholesterol levels below 40 mg/dL for men and below 50 mg/dL for women are considered low and increase cardiovascular disease risk. Levels below 35 mg/dL are particularly concerning and associated with significantly higher risks of heart disease and stroke.

How quickly can I raise my HDL cholesterol levels?

HDL cholesterol levels can begin to improve within 2-3 months of consistent lifestyle changes, particularly regular aerobic exercise. Significant improvements typically take 3-6 months of sustained effort, with exercise being the most effective intervention for raising HDL levels.

Can medications help increase HDL cholesterol?

While lifestyle changes are the primary approach for raising HDL, certain medications like niacin and fibrates can modestly increase HDL levels. However, these are typically reserved for high-risk patients and should only be used under medical supervision due to potential side effects.

Is it possible to have HDL cholesterol that's too high?

While rare, extremely high HDL levels (above 100 mg/dL) may sometimes indicate underlying health issues or genetic conditions. However, for most people, higher HDL levels within the normal range provide greater cardiovascular protection.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details